NCT00004029View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 31, 1996

Primary Completion Date

May 31, 2006

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

recombinant viral vaccine therapy

BIOLOGICAL

sargramostim

Trial Locations (3)

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00004029 - Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter